Robin Re of Industry Dive writes, “Since its launch three years ago, InsightCity has been on a mission to take the most important health industry news stories each week, summarize them in context within a weekly newsletter, and makes professionals smarter for the short time invested.
“Now under the stewardship of BioPharma Dive, InsightCity readers will be served with a more in-depth view of the biotech and pharma industries every day. This new chapter marks an exciting milestone and will provide readers with access to more content, reporting, and insights — all while maintaining the same dedication to making them smarter.
“With a community of almost 200,000 active readers, BioPharma Dive is a trusted name in biotech and pharma industry news. With daily insight on everything from gene therapies and biosimilars to big pharma dealmaking and drug pricing, BioPharma Dive provides a unique industry perspective.”
To read more, go here.
Financial Times reporter Simon Foy is now covering European banks. He has been covering accounting for the…
Debtwire, the leading provider of global fixed income news, analysis and data for more than…
Amber Kanwar, an anchor for BNN Bloomberg in Canada, is departing at the end of…
Moody's Ratings has promoted Yvette Kantrow to senior vice president and editor in chief. She has been…
Politico reporter Clare Fieseler is leaving the news organization to take on some ocean reporting projects. She…
Wall Street Journal reporter Ben Eisen has signed a contract with Norton to write a book about…